_id
6911bdf5ccc777a4e85d6292
Ticker
GMVDF
Name
G Medical Innovations Holdings Ltd
Exchange
PINK
Address
5 Oppenheimer Street, Rehovot, Israel, 7670105
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://gmedinnovations.com
Description
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.
Last Close
0.0002
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-03T12:45:44.496Z
Image
-
Ipo Date
-
Market Cap
51983
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2022-06-30
Revenue
2224000
Cost Of Revenue
7141000
Gross Profit
-4917000
Operating Expenses
15872000
Operating Income
-20789000
Interest Expense
4409000
Pretax Income
-13274000
Net Income
-13021000
Eps
-25.310279810673432
Dividends Per Share
-
Shares Outstanding
259918181
Income Tax Expense
13000
EBITDA
-8247000
Operating Margin
-934.7571942446043
Total Other Income Expense Net
7515000
Cash
1509000
Short Term Investments
-
Receivables
1900000
Inventories
2338000
Total Current Assets
5918000
Property Plant Equipment
4048000
Total Assets
10278000
Payables
3458000
Short Term Debt
1273000
Long Term Debt
60000
Total Liabilities
11518000
Equity
-4193000
Bs_currency_symbol
USD
Depreciation
618000
Change In Working Capital
-1554000
Cash From Operations
-16429000
Capital Expenditures
1790999
Cash From Investing
-1800000
Cash From Financing
13703000
Net Change In Cash
-2262500
Cf_currency_symbol
USD
PE
-
PB
-0.000012269377533985215
ROE
310.54137848795614
ROA
-126.6880716092625
FCF
-18219999
Fcf Percent
-8.19244559352518
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2022-06-30
Quarters > 0 > income Statement > revenue
2224000
Quarters > 0 > income Statement > cost Of Revenue
7141000
Quarters > 0 > income Statement > gross Profit
-4917000
Quarters > 0 > income Statement > operating Expenses
15872000
Quarters > 0 > income Statement > operating Income
-20789000
Quarters > 0 > income Statement > interest Expense
4409000
Quarters > 0 > income Statement > pretax Income
-13274000
Quarters > 0 > income Statement > net Income
-13021000
Quarters > 0 > income Statement > eps
-25.310279810673432
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
514455
Quarters > 0 > income Statement > income Tax Expense
13000
Quarters > 0 > income Statement > EBITDA
-8247000
Quarters > 0 > income Statement > operating Margin
-934.7571942446043
Quarters > 0 > income Statement > total Other Income Expense Net
7515000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1509000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1900000
Quarters > 0 > balance Sheet > inventories
2338000
Quarters > 0 > balance Sheet > total Current Assets
5918000
Quarters > 0 > balance Sheet > property Plant Equipment
4048000
Quarters > 0 > balance Sheet > total Assets
10278000
Quarters > 0 > balance Sheet > payables
3458000
Quarters > 0 > balance Sheet > short Term Debt
1273000
Quarters > 0 > balance Sheet > long Term Debt
60000
Quarters > 0 > balance Sheet > total Liabilities
11518000
Quarters > 0 > balance Sheet > equity
-4193000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-13021000
Quarters > 0 > cash Flow > depreciation
618000
Quarters > 0 > cash Flow > change In Working Capital
-1554000
Quarters > 0 > cash Flow > cash From Operations
-16429000
Quarters > 0 > cash Flow > capital Expenditures
1790999
Quarters > 0 > cash Flow > cash From Investing
-1800000
Quarters > 0 > cash Flow > cash From Financing
13703000
Quarters > 0 > cash Flow > net Change In Cash
-2262500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-25.310279810673432
Quarters > 0 > ratios > PB
-0.000012269377533985215
Quarters > 0 > ratios > ROE
310.54137848795614
Quarters > 0 > ratios > ROA
-126.6880716092625
Quarters > 0 > ratios > FCF
-18219999
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-8.19244559352518
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2022-03-31
Quarters > 1 > income Statement > revenue
2133000
Quarters > 1 > income Statement > cost Of Revenue
1772000
Quarters > 1 > income Statement > gross Profit
361000
Quarters > 1 > income Statement > operating Expenses
7357000
Quarters > 1 > income Statement > operating Income
-6996000
Quarters > 1 > income Statement > interest Expense
3542000
Quarters > 1 > income Statement > pretax Income
-10115000
Quarters > 1 > income Statement > net Income
-10064000
Quarters > 1 > income Statement > eps
-25.94001628983535
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
387972
Quarters > 1 > income Statement > income Tax Expense
2000
Quarters > 1 > income Statement > EBITDA
-5902000
Quarters > 1 > income Statement > operating Margin
-327.98874824191284
Quarters > 1 > income Statement > total Other Income Expense Net
-3119000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6034000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
985000
Quarters > 1 > balance Sheet > inventories
355000
Quarters > 1 > balance Sheet > total Current Assets
8551000
Quarters > 1 > balance Sheet > property Plant Equipment
1753000
Quarters > 1 > balance Sheet > total Assets
10517000
Quarters > 1 > balance Sheet > payables
2332000
Quarters > 1 > balance Sheet > short Term Debt
2794000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13329000
Quarters > 1 > balance Sheet > equity
-6031000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-10064000
Quarters > 1 > cash Flow > depreciation
671000
Quarters > 1 > cash Flow > change In Working Capital
-4528000
Quarters > 1 > cash Flow > cash From Operations
-10330000
Quarters > 1 > cash Flow > capital Expenditures
549999
Quarters > 1 > cash Flow > cash From Investing
-83000
Quarters > 1 > cash Flow > cash From Financing
3068000
Quarters > 1 > cash Flow > net Change In Cash
-2262500
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-25.94001628983535
Quarters > 1 > ratios > PB
-0.000006432963024374068
Quarters > 1 > ratios > ROE
166.87116564417178
Quarters > 1 > ratios > ROA
-95.69268802890558
Quarters > 1 > ratios > FCF
-10879999
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-5.100796530707923
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2021-06-30
Quarters > 2 > income Statement > revenue
2925000
Quarters > 2 > income Statement > cost Of Revenue
1784000
Quarters > 2 > income Statement > gross Profit
1141000
Quarters > 2 > income Statement > operating Expenses
5414000
Quarters > 2 > income Statement > operating Income
-4273000
Quarters > 2 > income Statement > interest Expense
950000
Quarters > 2 > income Statement > pretax Income
-4776000
Quarters > 2 > income Statement > net Income
-4694000
Quarters > 2 > income Statement > eps
-17.85001273914416
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
262969
Quarters > 2 > income Statement > income Tax Expense
-5000
Quarters > 2 > income Statement > EBITDA
-3135000
Quarters > 2 > income Statement > operating Margin
-146.0854700854701
Quarters > 2 > income Statement > total Other Income Expense Net
-503000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
13380000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1390000
Quarters > 2 > balance Sheet > inventories
46000
Quarters > 2 > balance Sheet > total Current Assets
15445000
Quarters > 2 > balance Sheet > property Plant Equipment
1542000
Quarters > 2 > balance Sheet > total Assets
17220000
Quarters > 2 > balance Sheet > payables
3302000
Quarters > 2 > balance Sheet > short Term Debt
2526000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10570000
Quarters > 2 > balance Sheet > equity
3378000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-4694000
Quarters > 2 > cash Flow > depreciation
691000
Quarters > 2 > cash Flow > change In Working Capital
2428000
Quarters > 2 > cash Flow > cash From Operations
-1164000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
66000
Quarters > 2 > cash Flow > cash From Financing
14199000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-17.85001273914416
Quarters > 2 > ratios > PB
0.00000778475429248076
Quarters > 2 > ratios > ROE
-138.9579632918887
Quarters > 2 > ratios > ROA
-27.25900116144019
Quarters > 2 > ratios > FCF
-1164000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.39794871794871794
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2020-12-31
Quarters > 3 > income Statement > revenue
2890000
Quarters > 3 > income Statement > cost Of Revenue
1699000
Quarters > 3 > income Statement > gross Profit
1191000
Quarters > 3 > income Statement > operating Expenses
8857000
Quarters > 3 > income Statement > operating Income
-7666000
Quarters > 3 > income Statement > interest Expense
189000
Quarters > 3 > income Statement > pretax Income
-7716000
Quarters > 3 > income Statement > net Income
-7636000
Quarters > 3 > income Statement > eps
-29.353989274799623
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
260135
Quarters > 3 > income Statement > income Tax Expense
-9000
Quarters > 3 > income Statement > EBITDA
-7140000
Quarters > 3 > income Statement > operating Margin
-265.25951557093424
Quarters > 3 > income Statement > total Other Income Expense Net
-50000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
908000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1287000
Quarters > 3 > balance Sheet > inventories
218000
Quarters > 3 > balance Sheet > total Current Assets
3135000
Quarters > 3 > balance Sheet > property Plant Equipment
2315000
Quarters > 3 > balance Sheet > total Assets
5450000
Quarters > 3 > balance Sheet > payables
4068000
Quarters > 3 > balance Sheet > short Term Debt
2356000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8399000
Quarters > 3 > balance Sheet > equity
-6298000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-7636000
Quarters > 3 > cash Flow > depreciation
387000
Quarters > 3 > cash Flow > change In Working Capital
-519000
Quarters > 3 > cash Flow > cash From Operations
-2318000
Quarters > 3 > cash Flow > capital Expenditures
299999
Quarters > 3 > cash Flow > cash From Investing
-330000
Quarters > 3 > cash Flow > cash From Financing
2389000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-29.353989274799623
Quarters > 3 > ratios > PB
-0.000004130438234360114
Quarters > 3 > ratios > ROE
121.24483963162909
Quarters > 3 > ratios > ROA
-140.11009174311926
Quarters > 3 > ratios > FCF
-2617999
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.9058820069204152
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
4420000
Annuals > 0 > income Statement > cost Of Revenue
3636000
Annuals > 0 > income Statement > gross Profit
784000
Annuals > 0 > income Statement > operating Expenses
22897000
Annuals > 0 > income Statement > operating Income
-22113000
Annuals > 0 > income Statement > interest Expense
4078000
Annuals > 0 > income Statement > pretax Income
-13942000
Annuals > 0 > income Statement > net Income
-24629000
Annuals > 0 > income Statement > eps
-34.16641927491558
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
720854
Annuals > 0 > income Statement > income Tax Expense
16000
Annuals > 0 > income Statement > EBITDA
-8652000
Annuals > 0 > income Statement > operating Margin
-500.29411764705884
Annuals > 0 > income Statement > total Other Income Expense Net
8171000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
295000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
944000
Annuals > 0 > balance Sheet > inventories
292000
Annuals > 0 > balance Sheet > total Current Assets
1993000
Annuals > 0 > balance Sheet > property Plant Equipment
2647000
Annuals > 0 > balance Sheet > total Assets
4825000
Annuals > 0 > balance Sheet > payables
4655000
Annuals > 0 > balance Sheet > short Term Debt
1809000
Annuals > 0 > balance Sheet > long Term Debt
53000
Annuals > 0 > balance Sheet > total Liabilities
9396000
Annuals > 0 > balance Sheet > equity
-7353000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-25066000
Annuals > 0 > cash Flow > depreciation
1212000
Annuals > 0 > cash Flow > change In Working Capital
1840000
Annuals > 0 > cash Flow > cash From Operations
-18479000
Annuals > 0 > cash Flow > capital Expenditures
2121000
Annuals > 0 > cash Flow > cash From Investing
-2123000
Annuals > 0 > cash Flow > cash From Financing
14863000
Annuals > 0 > cash Flow > net Change In Cash
-5739000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-34.16641927491558
Annuals > 0 > ratios > PB
-0.000019607071943424454
Annuals > 0 > ratios > ROE
334.95172038623696
Annuals > 0 > ratios > ROA
-510.44559585492226
Annuals > 0 > ratios > FCF
-20600000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.660633484162896
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
4961000
Annuals > 1 > income Statement > cost Of Revenue
3452000
Annuals > 1 > income Statement > gross Profit
1509000
Annuals > 1 > income Statement > operating Expenses
12477000
Annuals > 1 > income Statement > operating Income
-10968000
Annuals > 1 > income Statement > interest Expense
4492000
Annuals > 1 > income Statement > pretax Income
-14590000
Annuals > 1 > income Statement > net Income
-14758000
Annuals > 1 > income Statement > eps
-45.48592704005523
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
324452
Annuals > 1 > income Statement > income Tax Expense
-3000
Annuals > 1 > income Statement > EBITDA
-8736000
Annuals > 1 > income Statement > operating Margin
-221.08445877847208
Annuals > 1 > income Statement > total Other Income Expense Net
-3622000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6034000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
985000
Annuals > 1 > balance Sheet > inventories
355000
Annuals > 1 > balance Sheet > total Current Assets
8551000
Annuals > 1 > balance Sheet > property Plant Equipment
1753000
Annuals > 1 > balance Sheet > total Assets
10517000
Annuals > 1 > balance Sheet > payables
2332000
Annuals > 1 > balance Sheet > short Term Debt
2794000
Annuals > 1 > balance Sheet > long Term Debt
4782000
Annuals > 1 > balance Sheet > total Liabilities
13329000
Annuals > 1 > balance Sheet > equity
-6031000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-14888000
Annuals > 1 > cash Flow > depreciation
1362000
Annuals > 1 > cash Flow > change In Working Capital
-2105000
Annuals > 1 > cash Flow > cash From Operations
-11494000
Annuals > 1 > cash Flow > capital Expenditures
550000
Annuals > 1 > cash Flow > cash From Investing
-17000
Annuals > 1 > cash Flow > cash From Financing
17267000
Annuals > 1 > cash Flow > net Change In Cash
5756000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-45.48592704005523
Annuals > 1 > ratios > PB
-0.000010759476040457636
Annuals > 1 > ratios > ROE
244.70237108273918
Annuals > 1 > ratios > ROA
-140.32518779119522
Annuals > 1 > ratios > FCF
-12044000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.4277363434791375
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
4900000
Annuals > 2 > income Statement > cost Of Revenue
4233000
Annuals > 2 > income Statement > gross Profit
667000
Annuals > 2 > income Statement > operating Expenses
12967000
Annuals > 2 > income Statement > operating Income
-12300000
Annuals > 2 > income Statement > interest Expense
750000
Annuals > 2 > income Statement > pretax Income
-12706000
Annuals > 2 > income Statement > net Income
-12536000
Annuals > 2 > income Statement > eps
-59.675346313133716
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
210070
Annuals > 2 > income Statement > income Tax Expense
-18000
Annuals > 2 > income Statement > EBITDA
-10538000
Annuals > 2 > income Statement > operating Margin
-251.0204081632653
Annuals > 2 > income Statement > total Other Income Expense Net
-406000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
278000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1287000
Annuals > 2 > balance Sheet > inventories
90000
Annuals > 2 > balance Sheet > total Current Assets
3135000
Annuals > 2 > balance Sheet > property Plant Equipment
2315000
Annuals > 2 > balance Sheet > total Assets
5450000
Annuals > 2 > balance Sheet > payables
4068000
Annuals > 2 > balance Sheet > short Term Debt
2356000
Annuals > 2 > balance Sheet > long Term Debt
448000
Annuals > 2 > balance Sheet > total Liabilities
8399000
Annuals > 2 > balance Sheet > equity
-6298000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12688000
Annuals > 2 > cash Flow > depreciation
1418000
Annuals > 2 > cash Flow > change In Working Capital
1040000
Annuals > 2 > cash Flow > cash From Operations
-4647000
Annuals > 2 > cash Flow > capital Expenditures
506999
Annuals > 2 > cash Flow > cash From Investing
-455000
Annuals > 2 > cash Flow > cash From Financing
5380000
Annuals > 2 > cash Flow > net Change In Cash
278000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-59.675346313133716
Annuals > 2 > ratios > PB
-0.000006671006668783741
Annuals > 2 > ratios > ROE
199.04731660844712
Annuals > 2 > ratios > ROA
-230.01834862385323
Annuals > 2 > ratios > FCF
-5153999
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.0518365306122448
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
5526000
Annuals > 3 > income Statement > cost Of Revenue
5749000
Annuals > 3 > income Statement > gross Profit
-223000
Annuals > 3 > income Statement > operating Expenses
12556000
Annuals > 3 > income Statement > operating Income
-12779000
Annuals > 3 > income Statement > interest Expense
3850000
Annuals > 3 > income Statement > pretax Income
-16366000
Annuals > 3 > income Statement > net Income
-15509000
Annuals > 3 > income Statement > eps
-7.004066775505412
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2214285
Annuals > 3 > income Statement > income Tax Expense
-857000
Annuals > 3 > income Statement > EBITDA
-9646000
Annuals > 3 > income Statement > operating Margin
-231.252262034021
Annuals > 3 > income Statement > total Other Income Expense Net
-3587000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
717000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1107000
Annuals > 3 > balance Sheet > inventories
378000
Annuals > 3 > balance Sheet > total Current Assets
2374000
Annuals > 3 > balance Sheet > property Plant Equipment
3481000
Annuals > 3 > balance Sheet > total Assets
8770000
Annuals > 3 > balance Sheet > payables
3329000
Annuals > 3 > balance Sheet > short Term Debt
12633000
Annuals > 3 > balance Sheet > long Term Debt
1292000
Annuals > 3 > balance Sheet > total Liabilities
18646000
Annuals > 3 > balance Sheet > equity
-13377000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-15509000
Annuals > 3 > cash Flow > depreciation
2870000
Annuals > 3 > cash Flow > change In Working Capital
2552000
Annuals > 3 > cash Flow > cash From Operations
-6297000
Annuals > 3 > cash Flow > capital Expenditures
429000
Annuals > 3 > cash Flow > cash From Investing
-429000
Annuals > 3 > cash Flow > cash From Financing
4104000
Annuals > 3 > cash Flow > net Change In Cash
-2634000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-7.004066775505412
Annuals > 3 > ratios > PB
-0.00003310585333034312
Annuals > 3 > ratios > ROE
115.93780369290573
Annuals > 3 > ratios > ROA
-176.84150513112883
Annuals > 3 > ratios > FCF
-6726000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.217155266015201
Annuals > 3 > health Score
31
Valuation > metrics > PE
-25.310279810673432
Valuation > metrics > PB
-0.000012269377533985215
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
310.54137848795614
Profitability > metrics > ROA
-220.023656640757
Profitability > metrics > Net Margin
-5.85476618705036
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.715128146972103
Risk > final Score
11
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.2508983301627563
Liquidity > metrics > Quick Ratio
0.756711054745297
Liquidity > final Score
69
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
22
Prev Risks > 1
-12
Prev Risks > 2
-132
Prev Liquidities > 0
92
Prev Liquidities > 1
100
Prev Liquidities > 2
33
Updated At
2026-01-20T21:54:52.011Z
Earnings History > 0 > period
2023-03-31
Earnings History > 0 > report Date
2023-05-16
Earnings History > 0 > date
2023-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.54
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.54
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-06-30
Earnings History > 1 > report Date
2021-09-15
Earnings History > 1 > date
2021-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.03
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-06-30
Earnings History > 2 > report Date
2020-08-31
Earnings History > 2 > date
2020-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-03-31
Earnings History > 3 > report Date
2020-04-07
Earnings History > 3 > date
2020-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.02
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2019-06-30
Earnings History > 4 > report Date
2019-09-02
Earnings History > 4 > date
2019-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2018-12-31
Earnings History > 5 > report Date
2019-03-04
Earnings History > 5 > date
2018-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2018-06-30
Earnings History > 6 > report Date
2018-08-30
Earnings History > 6 > date
2018-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.03
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2022-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of G Medical Innovations Holdings Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-03-31
EPS Actual
-0.54
EPS Estimate
0
EPS Difference
-0.54
Surprise Percent
0%
(Last Updated 2022-06-30)
(Last Updated 2022-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.